According to a recent study, comorbid chronic inflammatory diseases influence the prognosis of alopecia areata.

Patients with skin of color are less likely to be diagnosed with a borderline reaction to patch testing than patients with lighter skin tones.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

A recent study finds that genetically predicted rheumatoid arthritis is causally associated with prostate cancer.

Achievement of cancer remission was associated with dermatomyositis complete clinical response among patients with cancer-associated DM.

Fractional carbon dioxide laser treatments are effective at reducing postsurgical scarring, particularly in the first month after surgery.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via PEPFAR.

A scientific statement regarding nursing wellness in cardiovascular and stroke care has been published by the American Heart Association.

Long-term lebrikizumab was effective for atopic dermatitis treatment in patients who did not have adequate response to short-term treatment.

Women were a younger mean age at melanoma diagnosis when compared with men across all anatomic sites and most Breslow thickness categories.